The atypical sphingosine 1‐phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma-Reference-Cited by-同舟云学术

The atypical sphingosine 1‐phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma

Published:2022-04-03 Issue:18 Volume:289 Page:5670-5681
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:The FEBS Journal

Author:

Glueck Melanie¹,Koch Alexander¹,Brunkhorst Robert²,Ferreiros Bouzas Nerea³,Trautmann Sandra³,Schaefer Liliana¹,Pfeilschifter Waltraud¹⁴,Pfeilschifter Josef¹,Vutukuri Rajkumar¹

Affiliation:

1. Institute of General Pharmacology and Toxicology University Hospital and Goethe University Frankfurt Germany

2. Department of Neurology University Hospital RWTH Aachen Germany

3. Institute of Clinical Pharmacology University Hospital and Goethe University Frankfurt Germany

4. Department of Neurology Klinikum Lueneburg Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.16446

Reference47 articles.

1. Renal cell carcinoma

2. The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions

3. Renal fibrosis: novel insights into mechanisms and therapeutic targets

4. Significance of Intratumoral Fibrosis in Clear Cell Renal Cell Carcinoma

5. Renal tubulointerstitial fibrosis: common but never simple

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling;Metabolites;2023-03-14

2. Lipids as Targets for Renal Cell Carcinoma Therapy;International Journal of Molecular Sciences;2023-02-07

3. Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism;International Journal of Molecular Sciences;2022-09-28